Home

Kessel Damit Tablette anthracycline cumulative dose Palast Zensur Genau

Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment | SpringerLink
Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment | SpringerLink

Conversion factor for the anthracyclines [8] | Download Table
Conversion factor for the anthracyclines [8] | Download Table

Risk factors associated with anthracycline- induced cardiotoxicity. | Download Table
Risk factors associated with anthracycline- induced cardiotoxicity. | Download Table

The Cardiotoxicity of Cancer-Related Drug Therapies
The Cardiotoxicity of Cancer-Related Drug Therapies

Prevention of Anthracycline- induced Cardiotoxicity
Prevention of Anthracycline- induced Cardiotoxicity

Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro
Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro

Chemotherapy And Cardiotoxicity
Chemotherapy And Cardiotoxicity

Survivorship: Managing Cardiac Toxicities
Survivorship: Managing Cardiac Toxicities

Survivorship: Managing Cardiac Toxicities
Survivorship: Managing Cardiac Toxicities

Frontiers | Novel Therapeutics for Anthracycline Induced Cardiotoxicity
Frontiers | Novel Therapeutics for Anthracycline Induced Cardiotoxicity

Equivalent Doses of Anthracyclines Based on Substitution Rules and... | Download Table
Equivalent Doses of Anthracyclines Based on Substitution Rules and... | Download Table

Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). | Semantic Scholar
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). | Semantic Scholar

Learning from an anthracycline error
Learning from an anthracycline error

Anthracycline-Induced Cardiotoxicity in Adults
Anthracycline-Induced Cardiotoxicity in Adults

Anthracycline and their cumulative life time dose. 19-25 | Download Table
Anthracycline and their cumulative life time dose. 19-25 | Download Table

Cumulative anthracycline dose and cardiotoxicity in subgroups at... | Download Table
Cumulative anthracycline dose and cardiotoxicity in subgroups at... | Download Table

Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity - American Journal of Cardiology
Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity - American Journal of Cardiology

crt-40-121-i001.jpg
crt-40-121-i001.jpg

Survivorship: Managing Cardiac Toxicities
Survivorship: Managing Cardiac Toxicities

Anthracycline-Induced Cardiotoxicity in Adults
Anthracycline-Induced Cardiotoxicity in Adults

Anthracycline and their cumulative life time dose. 19-25 | Download Table
Anthracycline and their cumulative life time dose. 19-25 | Download Table

Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology

Anthracycline-Induced Cardiotoxicity in Adult Hematologic Malignancies - ScienceDirect
Anthracycline-Induced Cardiotoxicity in Adult Hematologic Malignancies - ScienceDirect

Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro
Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro

Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies - Annals of Oncology
Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies - Annals of Oncology

Anthracycline-Induced Cardiotoxicity in Adults
Anthracycline-Induced Cardiotoxicity in Adults

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology